Compare BCPC & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCPC | PLXS |
|---|---|---|
| Founded | 1967 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Electrical Products |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.3B |
| IPO Year | N/A | 1986 |
| Metric | BCPC | PLXS |
|---|---|---|
| Price | $173.25 | $200.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $176.00 | ★ $194.00 |
| AVG Volume (30 Days) | 156.7K | ★ 377.1K |
| Earning Date | 02-20-2026 | 01-28-2026 |
| Dividend Yield | ★ 0.55% | N/A |
| EPS Growth | 22.48 | ★ 49.29 |
| EPS | 4.57 | ★ 6.43 |
| Revenue | $1,013,548,000.00 | ★ $4,126,696,000.00 |
| Revenue This Year | $10.41 | $10.99 |
| Revenue Next Year | $6.36 | $7.02 |
| P/E Ratio | $38.10 | ★ $30.51 |
| Revenue Growth | ★ 7.55 | 4.36 |
| 52 Week Low | $139.17 | $103.43 |
| 52 Week High | $177.40 | $208.92 |
| Indicator | BCPC | PLXS |
|---|---|---|
| Relative Strength Index (RSI) | 68.11 | 69.32 |
| Support Level | $167.80 | $193.49 |
| Resistance Level | $176.35 | $208.92 |
| Average True Range (ATR) | 3.41 | 9.51 |
| MACD | 0.46 | 1.72 |
| Stochastic Oscillator | 75.78 | 78.14 |
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.